Skip to main content

Augmentation of tumor antigen expression by recombinant human interferons: Enhanced targeting of monoclonal antibodies to carcinomas

  • Chapter
Cancer Imaging with Radiolabeled Antibodies

Abstract

The advent of hybridoma technology has provided an unlimited supply of monoclonal, ‘monospecific’ antibodies (Mab) that has fueled an unprecedented surge in the study of tumor immunology and biology [1]. For the first time, investigators have at their disposal a continuous source of pure antibody that makes possible the identification and extensive characterization of a wide variety of tumor antigens expressed by human carcinomas, melanomas, leukemias, and lymphomas. Subsequent studies have also led to the development of novel assays using Mabs for tumor diagnosis [2–5], as well as a variety of clinical protocols demonstrating radioimmunolocalization of an antibody to occult lesions in a variety of cancer patients [6–15]. In addition to these clinical studies, the use of immunohistochemical techniques, radioimmunoassays (RIA), Western blotting, and other experimental analyses have led to a better understanding of some of the basic principles that characterize tumor antigen expression.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kohler, M., and Milstein, C. (1975) Continuous cultures of fused cells secreting antibody of pre-defined specificity. Nature 256:295–297.

    Article  Google Scholar 

  2. Bast, R.C., Jr., Klug, T.L., St. John, E., Jenison, E., Niloff, J.M., Lazarus, H., Berkowitz, R.S., Leavitt, T., Griffiths, T., Parker, L., Zurawski, V.R. Jr., and Knapp, R.C. (1983) A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N. Engl. J. Med. 309:883–887.

    Article  PubMed  Google Scholar 

  3. Metzgar, R.A., Rodriguez, N., Finn, O.J., Lan, M.S., Daasch, V.N., Fernsten, P.D., Meyers, W.C., Sindelar, W.F., Sandler, R.S., and Seigier, H.F. (1984) Detection of a pancreatic cancer associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc. Natl. Acad. Sci. USA 81:5242–5246.

    Article  PubMed  CAS  Google Scholar 

  4. Ritts, R.E., Del Villano, B.C., Go, W.L.M., Herberman, R.B., Klug, T.L., and Zurawski, V.R., Jr. (1984) Initial clinical evaluation of an immunoradiometric assay for CA 19–9 using the NCI serum bank. Int. J. Cancer 33:339–345.

    Article  PubMed  Google Scholar 

  5. Klug, T.L., Sattler, M.A., Colcher, D., and Schlom, J. (1986) Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 72) on a novel pancarcinoma antigen (TAG-72). Int. J. Cancer 38:661–669.

    Article  PubMed  CAS  Google Scholar 

  6. Mach, J.P., Buchegger, F., Forni, M., Ritschard, J., Berche, C., Lumbroso, J.D., Schreyer, M., Girardet, C., Accolla, R.S., and Carrel, S. (1981) Use of radiolabeled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy. Immunol. Today 2:239–249.

    Article  Google Scholar 

  7. Moldofsky, P.J., Powe, J., Mulhern, C.B., Jr., Hammond, N., Sears, H.F., Gatenby, R.A., Steplewski, Z., and Koprowski, H. (1983) Metastatic colon carcinoma detected with radiolabeled F(ab’)2 monoclonal antibody fragments. Radiology 149:549–555.

    PubMed  CAS  Google Scholar 

  8. Mach, J.P., Chatal, J.F., Lumbroso, J.D., Buchegger, F., Forni, M., Ritschard, J., Berche, C., Douillard, J.Y., Carrel, S., Herlyn, M., Steplewski, Z., and Koprowski, H. (1983) Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma. Cancer Res. 43:5593–5600.

    PubMed  CAS  Google Scholar 

  9. Hontowich, D.J., Griffin, T.W., Kosciuczyk, C., Rusckowski, M., Childs, R.L., Mattis, J.A., Shealy, D., and Doherty, P.W. (1985) Pharmacokinetics of an indium-111 labeled monoclonal antibody in cancer patient. J. Nucl. Med. 26:849–858.

    Google Scholar 

  10. Epenetos, A.A., Britton, K.E., Mather, S., Shepherd, J., Granowska, M., Taylor-Papadimitriou, J., Nimmon, C.C., Durbin, H., Hawkins, L.R., Malpas, J.S., and Bodmer, W.F. (1982) Targeting of iodine-123-labeled tumor-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumors. Lancet 2:999–1004.

    Article  PubMed  CAS  Google Scholar 

  11. Murray, J.L., Rosenblum, M.G., Sobol, R.E., Bartholomew, R.M., Plager, C.E., Haynie, T.P., Jahns, M.F., Glenn, H.J., Lamki, L., Benjamin, R.S., Papadopoulos, N., Boddie, A.W., Frincke, J.M., David, G.S., Carlo, D.J., and Hersh, E.M. (1985) Radioimmuno-imaging in malignant melanoma with 111In-labeled monoclonal antibody 96.5. Cancer Res. 45:2376–2381.

    PubMed  CAS  Google Scholar 

  12. Larson, S.M. (1985) Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy. J. Nucl. Med. 26:538–545.

    PubMed  CAS  Google Scholar 

  13. Epenetos, A.A., Hooker, G., Krausz, T., Snook, D., Bodmer, W.F., and Taylor-Papadimitriou, J. (1986) Antibody-guided irradiation of malignant ascites in ovarian cancer: A new therapeutic method possessing specificity against cancer cells. Obstet. Gynecol. 68: 715–745.

    Google Scholar 

  14. Colcher, D., Esteban, J.E., Carrasquillo, J.A., Sugarbaker, P., Reynolds, J.C., Bryant, G., Larson, S.M., and Schlom, J. (1987) Quantitative analysis of selective radiolabeled monoclonal antibody localization in metastatic lesions of colorectal cancer patients. Cancer Res. 47:1185–1189.

    PubMed  CAS  Google Scholar 

  15. Colcher, D., Esteban, J.E., Carrasquillo, J.A., Reynolds, J.C., Bryant, G., Larson, S.M., and Schlom, J. (1987) Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma. Cancer Res. 47:4218–4224.

    PubMed  CAS  Google Scholar 

  16. Colcher, D., Hand, P., Nuti, M., and Schlom, J. (1981) A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc. Natl. Acad. Sci. USA 78:3199–3203.

    Article  PubMed  CAS  Google Scholar 

  17. Nuti, M., Teramoto, Y.A., Mariani-Costantini, R., Horan Hand, P., Colcher, D., and Schlom, J. (1982) A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell population. Int. J. Cancer 29: 539–545.

    Article  PubMed  CAS  Google Scholar 

  18. Johnson, V.G., Schlom, J., Paterson, A.J., Bennett, J., Magnani, J.L., and Colcher, D. (1986) Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Cancer Res. 46:850–857.

    PubMed  CAS  Google Scholar 

  19. Thor, A., Viglione, M.J., Muraro, R., Ohuchi, N., Schlom, J., and Gorstein, F. (1987) Monoclonal antibody B72.3 reactivity with human endometrium: A study of normal and malignant tissues. Int. J. Gynecol. Oncol. 6:235–247.

    CAS  Google Scholar 

  20. Thor, A., Ohuchi, N., Szpak, C.A., Johnston, W.W., and Schlom, J. (1986) The distribution of oncofetal antigen TAG-72 recognized by monoclonal antibody B72.3. Cancer Res. 46: 3118–3124.

    PubMed  CAS  Google Scholar 

  21. Horan Hand, P., Nuti, M., Colcher, D., and Schlom, J. (1983) Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens, Cancer Res. 43:728–735.

    PubMed  CAS  Google Scholar 

  22. Schlom, J., Colcher, D., Horan Hand, P., Wunderlich, D., Nuti, M., and Teramoto, Y.A. (1983) Antigenic heterogeneity, modulation and evolution in breast cancer lesions as defined by monoclonal antibodies. In: Rich, M., Hager, J., and Furmanski, P. (eds.), Understanding Breast Cancer: Clinical and Laboratory Concepts. New York: Marcel Dekker, pp. 169–213.

    Google Scholar 

  23. Barnstable, C.J., Bodmer, W.F., Brown, G., Galfre, G., Milstein, C., Williams, A.F., and Ziegler, A. (1978) Production of monoclonal antibodies to group A erythrocytes, HLA and to the human cell surface antigens — new tools for genetic analysis. Cell 14:9–20.

    Article  PubMed  CAS  Google Scholar 

  24. Tran, R., Horan Hand, P., Greiner, J.W., Pestka, S., and Schlom, J. (1988) Enhancement of surface antigen expression on human breast carcinoma cells by recombinant human interferons. J. Interferon Res. 8:75–88.

    Article  PubMed  CAS  Google Scholar 

  25. Muraro, R., Wunderlich, P., Thor, A., Lundy, J., Noguchi, P., Cunningham, R., and Schlom, J. (1985) Definition of monoclonal antibodies of a repertoire of epitopes in carcino-embryonic antigen differentially expressed in human colon carcinoma versus normal adult tissues. Cancer Res. 45:5769–5780.

    PubMed  CAS  Google Scholar 

  26. Foulds, L. (1954) The experimental study of tumor progression: A review. Cancer Res. 14: 327–329.

    PubMed  CAS  Google Scholar 

  27. Kufe, D.W., Nadler, L., Sargent, L., Shapiro, H., Horan Hand, P., Austin, F., Colcher, D., and Schlom, J. (1983) Biological behavior of human breast carcinoma-associated antigens expressed during cellular proliferation. Cancer Res. 43:851–857.

    PubMed  CAS  Google Scholar 

  28. Greiner, J.W., Tobi, M., Fisher, P.B., Langer, J.A., and Pestka, S. (1985) Differential responsiveness of cloned mammary carcinoma cell populations to human recombinant leukocyte alpha interferon mediated enhancement of human antigen expression. Int. J. Cancer 36:159–166.

    Article  PubMed  CAS  Google Scholar 

  29. Horan Hand, P., Colcher, D., Salomon, D., Ridge, J., Noguchi, P., and Schlom, J. (1985) Spacial configuration of carcinoma cell populations influences the expression of a tumor associated glycoprotein. Cancer Res. 45:833–840.

    Google Scholar 

  30. Fellous, M., Kamoun, M., Gresser, I., and Bono, R. (1979) Enhanced expression of HLA antigens and β2-microglobulin on interferon-treated human lymphoid cells. Eur. J. Immunol. 9:446–449.

    Article  PubMed  CAS  Google Scholar 

  31. Attallah, A.M., Needy, C.F., Noguchi, P.D., and Elisberg, B.L. (1979) Enhancement of carcinoembryonic antigen expression by interferon. Int. J. Cancer 24:49–52.

    Article  PubMed  CAS  Google Scholar 

  32. Imai, K., Ng, A.-K., Glassy, M., and Ferrone, S.K. (1981) Differential effect of interferon on the expression of tumor-associated antigens and histocompatibility antigens on human melanoma cells: Relationship to susceptibility to immune lysis mediated by monoclonal antibodies. J. Immunol. 127:505–508.

    PubMed  CAS  Google Scholar 

  33. Basham, T.Y., Bourgeade, M.F., Creasey, A.A., and Merigan, T.C. (1982) Interferon increases HLA synthesis in melanoma cells: Interferon-resistant and sensitive cell lines. Proc. Natl. Acad. Sci. USA 79:3265–3269.

    Article  PubMed  CAS  Google Scholar 

  34. Ball, E.D., Sorenson, G.D., and Pettengill, O.S. (1986) Expression of myeloid and major histocompatibility antigens on small cell carcinoma of the lung cells analyzed by cytofluorometry: Modulation by interferon. Cancer Res. 46:2335–2339.

    PubMed  CAS  Google Scholar 

  35. Greiner, J.W., Horan Hand, P., Noguchi, P., Fisher, P., Pestka, S., and Schlom, J. (1984) Recombinant interferon enhances detection of human breast and colon carcinoma associated antigens by monoclonal antibodies. Cancer Res. 44:3208.

    PubMed  CAS  Google Scholar 

  36. Dolei, A., Capobianchi, M.R., and Ameglio, F. (1983) Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta. Infect. Immunol. 40:172–176.

    CAS  Google Scholar 

  37. Schwartz, R., Momberg, F., Moldenbauer, G., Dorken, B., and Schirrmacher, V. (1985) Induction of class II antigen expression on human carcinoma cell lines by IFN-gamma. Int. J. Cancer 35:245–250.

    Article  PubMed  CAS  Google Scholar 

  38. Ziai, M.R., Imbesti, L., Tongson, A., and Ferrone, S. (1985) Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon. Cancer Res. 45:5877–5882.

    PubMed  CAS  Google Scholar 

  39. Greiner, J.W. (1986) Modulation of antigen expression in human tumor cell populations. Cancer Invest. 4:239.

    Article  PubMed  CAS  Google Scholar 

  40. Giacomini, P., Aguzzi, A., and Ferrone, S. (1986) Differential susceptibility to modulation by recombinant immune interferon of HLA-DR and -DO antigens synthesized by melanoma COLO 38 cells. Hybridoma 5:277–288.

    Article  PubMed  CAS  Google Scholar 

  41. Heron, I., Hokland, M., and Berg, K. (1978) Enhanced expression of β2-microglobulin and HLA antigen on human lymphoid cells by interferon. Proc. Natl. Acadi. Sci. USA 75: 6215–6219.

    Article  CAS  Google Scholar 

  42. Wallach, D., Fellous, M., and Revel, M. (1982) Preferential effect of gamma-interferon on the synthesis of HLA antigens and their mRNAs. Nature 299:833–836.

    Article  PubMed  CAS  Google Scholar 

  43. Collins, T., Karman, A.J., Wake, C.T., Boss, J.M., Kappes, D.J., Fiers, W., Ault, K.A., Gimbrone, M.A., Strominger, J.L., and Pober, J.S. (1984) Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc. Natl. Acad. Sci. USA 81:4917–4921.

    Article  PubMed  CAS  Google Scholar 

  44. Greiner, J.W., Guadagni, F., Pestka, S., and Schlom, J. (1986) Augmentation of antigen expression by recombinant human interferon. In: Friedman, R., Merigan, T., and Sreevalsan, T. (eds.), UCLA Symposium on Molecular and Cellular Biology, Vol 50. New York: Alan R. Liss, pp. 17–27.

    Google Scholar 

  45. Chandrabase, K., and Cuatrecasas, P. (1981) Changes in fatty acyl chains of phospholipid induced by interferon in mouse sarcoma S-180. Biochem. Biophys. Res. Commun. 98: 661–665.

    Article  Google Scholar 

  46. Kuhry, J.G., Poindoin, and Laustriat, G. (1983) Evidence for early fluidity changes in the plasma membranes of interferon treated L-cells, from fluorescence antistropy data. Biochem. Biophys. Res. Commun. 110:88–92.

    Article  PubMed  CAS  Google Scholar 

  47. Spear, G.T., Paulnock, D.M., Jordan, R., Hawkins, M.J., and Borden, E.C. (1985) Modulation of human peripheral blood monocyte HLA-DR expression by recombinant IFN-γ. Proc. Am. Assoc. Cancer Res. 26:277.

    Google Scholar 

  48. Rowlinson, G., Balkwill, F., Snook, D., Hooker, G., and Epenetos, A.A. (1986) Enhancement by γ-interferon of in vivo tumor radiolocalization by a monoclonal antibody against HLA-DR antigen. Cancer Res. 46:6413–6417.

    PubMed  CAS  Google Scholar 

  49. Balkwill, F.R., Stevens, M.H., Griffin, D.B., Thomas, J.A., and Bodmer, J.G. (1987) Interferon gamma regulates HLA-DR expression on solid tumors in vivo. Eur. J. Clin. Oncol. 23:101–106.

    Article  CAS  Google Scholar 

  50. Hayes, D.F., Zalutsky, M.R., Kaplan, W., Noska, M, Thor, A., Colcher, D., and Kufe, D.W. (1986) Pharmacokinetics of radiolabeled monoclonal antibody B6.2 in patients with metastatic breast cancer. Cancer Res. 46:3157–3163.

    PubMed  CAS  Google Scholar 

  51. Colcher, D., Zalutsky, M., Kaplan, W., Kufe, D., Austin, F., and Schlom, J. (1983) Radio-localization of human mammary tumors in athymic mice by a monoclonal antibody. Cancer Res. 43:736–742.

    PubMed  CAS  Google Scholar 

  52. Sahagan, B.G., Dorai, H., Saltygaber-Muller, J., Toneguzzo, F., Guidon, C.A., Lilly, S.P., McDonald, K.W., Morrissey, D.V., Stone, B.A., Davis, G.L., McIntosh, P.K., and Moore, G.P. (1986) A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen. J. Immunol. 137:1066–1074.

    PubMed  CAS  Google Scholar 

  53. Thor, A., Muraro, R., Gorstein, F., Ohuchi, N., Viglione, M., Szpak, C.A., Johnston, W.W., and Schlom, J. (1987) Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcino-embryonic antigen activity. Cancer Res. 47:505–512.

    PubMed  CAS  Google Scholar 

  54. Schlom, J., Greiner, J.W., Horan-Hand, P., Colcher, D., Inghirami, G., Weeks, M., Pestka, S., Fisher, P.B., Noguchi, P., and Kufe, D.W. (1985) Human breast cancer markers defined by monoclonal antibodies. In: Sell, S., and Reisfeld, R. (eds.), Monoclonal Antibodies in Cancer. Clifton, NJ: Humana Press, pp. 247–277.

    Google Scholar 

  55. Greiner, J.W., Horan Hand, P., Wunderlich, D., and Colcher, D. (1986) Radioimmunoassay for detection of changes in cell surface tumor antigen expression induced by interferon. Meth. Enzymol. 119:682–685.

    Article  PubMed  CAS  Google Scholar 

  56. Braylan, R.C., Benson, N.A., Nourse, V., and Kruth, H.S. (1982) Correlated analysis of cellular DNA, membrane antigens and light scatter of human lymphoid cells. Cytometry 2: 337–343.

    Article  PubMed  CAS  Google Scholar 

  57. Basham, T.Y., Kaminski, M.S., Kitamura, K., Levy, R., and Merigan, T.C. (1986) Synergistic antitumor effect of interferon and anti-idiotype monoclonal antibody in murine lymphoma. J. Immunol. 137:3019–3024.

    PubMed  CAS  Google Scholar 

  58. Herlyn, D., Powe, J., Ross, A.H., Herlyn, M., and Koprowski, H. (1985) Inhibition of human tumor growth by IgG2a monoclonal antibodies correlates with antibody density on tumor cells. J. Immunol. 134:1300–1304.

    PubMed  CAS  Google Scholar 

  59. Herlyn, D., and Koprowski, H. (1982) IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells. Proc. Natl. Acad. Sci. USA 79:4761–4768.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Kluwer Academic Publishers

About this chapter

Cite this chapter

Greiner, J.W. et al. (1990). Augmentation of tumor antigen expression by recombinant human interferons: Enhanced targeting of monoclonal antibodies to carcinomas. In: Goldenberg, D.M. (eds) Cancer Imaging with Radiolabeled Antibodies. Cancer Treatment and Research, vol 51. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1497-4_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1497-4_21

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8805-3

  • Online ISBN: 978-1-4613-1497-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics